Effectiveness of an Aerobic Exercise Program in Cancer Survivors.
Not Applicable
Not yet recruiting
- Conditions
- Aerobic Exercise
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06254989
Intervention for Employed Women With Multiple Sclerosis
Not Applicable
- Conditions
- Multiple Sclerosis
- Interventions
- Behavioral: Neuropsychological testing intervention plus follow up
- First Posted Date
- 2019-09-24
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT04100525
Effects of a Weight Based Training Program on MS Patients
Not Applicable
- Conditions
- Multiple Sclerosis
- Interventions
- Behavioral: Bodyweight training
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04002492
- Locations
- πΊπΈ
Holy Name Medical Center, Teaneck, New Jersey, United States
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- Device: Nanoknife Irreversible Electroporation
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03614910
- Locations
- πΊπΈ
Holy Name Medical Center, Teaneck, New Jersey, United States
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Completed
- Conditions
- Stomach CancerColorectal CancerOvarian CancerAppendiceal CancerPrimary Peritoneal CarcinomaUterine CancerCervical CancerFallopian Tube Cancer
- Interventions
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03604653
- Locations
- πΊπΈ
Holy Name Medical Center, Teaneck, New Jersey, United States
Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Holy Name Medical Center, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT03424733
- Locations
- πΊπΈ
Holy Name Medical Center, Teaneck, New Jersey, United States
Β© Copyright 2025. All Rights Reserved by MedPath